Product
Trastuzumab
Aliases
T-DM1, Trastuzumab emtansine
Name
trastuzumab
Target
HER2
FDA Approved
No
Ema approved
Status
0
1 clinical trial
1 drug
1 indication
Drug
T-DM1Indication
Breast cancerClinical trial
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)Status: Active (not recruiting), Estimated PCD: 2019-08-26